Trial Parameters
Condition Coronary Heart Disease
Sponsor Shandong First Medical University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-01-21
Completion 2027-01-21
All Conditions
Brief Summary
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Eligibility Criteria
Inclusion Criteria: * Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography. * Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects. Exclusion Criteria: * With malignant tumors, infectious diseases and advanced liver diseases. * Won't sign an inform consent.